/MLEC
MLEC Stock - Moolec Science S.A.
Healthcare|BiotechnologyNASDAQ
$0.33-2.37%
$0.01 (-2.37%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+820.0%upside
Target: $3.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MLEC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.32 – $0.33
TARGET (TP)$3.00
STOP LOSS$0.30
RISK/REWARD1:102.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.52
52W High$10.47
52W Low$0.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | $5.63M | $905,049 | N/A | N/A |
| Gross Profit | $472,581 | $-143,305 | N/A | N/A |
| Gross Margin | 8.4% | -15.8% | N/A | N/A |
| Operating Income | $-9,042,851 | $-6,653,805 | $-1,716,659 | $-13,800 |
| Net Income | $-7,312,260 | $-51,788,880 | $-4,526,905 | $-13,802 |
| Net Margin | -130.0% | -5722.2% | N/A | N/A |
| EPS | $-0.19 | $-1.50 | $-0.12 | $-0.00 |
Company Overview
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$5
Average Target
↑ 1433.3% Upside
Now
$5
Low
$5
Average
$5
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 27th 2023 | ROTH MKM | Initiation | Buy | $5 |
Earnings History & Surprises
MLECBeat Rate
50%
Last 6 quarters
Avg Surprise
-134.8%
EPS vs Estimate
Beats / Misses
3/1
2 met exactly
Latest EPS
$-0.60
Q2 2025
EPS Surprise History
Q4 23
No data
Q4 23
+20.0%
$-0.04vs$-0.05
Q1 24
0.0%
$-0.05vs$-0.05
Q2 24
+42.9%
$-0.04vs$-0.07
Q4 24
0.0%
$-0.07vs$-0.07
Q4 24
No data
Q1 25
+28.6%
$-0.05vs$-0.07
Q2 25
-900.0%
$-0.60vs$-0.06
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 14, 2026 | — | — | — | — |
Q1 2026 | Jan 30, 2026 | — | — | — | — |
Q4 2025 | Oct 27, 2025 | $-0.70 | — | — | — |
Q2 2025 | Apr 16, 2025 | $-0.06 | $-0.60 | -900.0% | ✗ MISS |
Q1 2025 | Jan 31, 2025 | $-0.07 | $-0.05 | +28.6% | ✓ BEAT |
Q4 2024 | Oct 18, 2024 | — | $-0.07 | — | — |
Q4 2024 | Oct 2, 2024 | $-0.07 | $-0.07 | 0.0% | = MET |
Q2 2024 | May 30, 2024 | $-0.07 | $-0.04 | +42.9% | ✓ BEAT |
Q1 2024 | Mar 13, 2024 | $-0.05 | $-0.05 | 0.0% | = MET |
Q4 2023 | Dec 14, 2023 | $-0.05 | $-0.04 | +20.0% | ✓ BEAT |
Q4 2023 | Oct 30, 2023 | — | $-0.07 | — | — |
Q3 2023 | Jul 10, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 30, 2023 | — | $-1.28 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.03 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.05 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.11 | — | — |
Q1 2021 | Mar 30, 2021 | — | $0.06 | — | — |
Frequently Asked Questions about MLEC
What is MLEC's current stock price?
Moolec Science S.A. (MLEC) is currently trading at $0.33 per share. The stock has moved -2.37% today.
What is the analyst price target for MLEC?
The average analyst price target for MLEC is $3.00, based on 1 analyst.
What sector is Moolec Science S.A. in?
Moolec Science S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is MLEC's market cap?
Moolec Science S.A. has a market capitalization of $0.00 billion, making it a small-cap company.
Does MLEC pay dividends?
No, Moolec Science S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorDRMA
Dermata Therapeutics, Inc.
$2.14
Mkt Cap: $0.0B
ELAB
PMGC Holdings Inc.
$2.26
Mkt Cap: $0.0B
GLMD
Galmed Pharmaceuticals Ltd.
$0.85
Mkt Cap: $0.0B
GTBP
GT Biopharma, Inc.
$0.76
Mkt Cap: $0.0B
NCEL
NewcelX Ltd.
$2.60
Mkt Cap: $0.0B
NKGN
NKGen Biotech, Inc. Common Stock
$0.05
Mkt Cap: $0.0B
TIVC
Tivic Health Systems, Inc.
$1.74
Mkt Cap: $0.0B
VRAX
Virax Biolabs Group Limited
$0.39
Mkt Cap: $0.0B
WINT
Windtree Therapeutics, Inc.
$0.04
Mkt Cap: $0.0B
XRTX
XORTX Therapeutics Inc.
$0.60
Mkt Cap: $0.0B
Explore stocks similar to MLEC for comparison